good explanation of why the app has not been successful at the coal face ..it works ..but culturally with GP it's not acceptable..either due to ego or ambivalence...that's. the problem ..large hmo ...and large corporate health care companies need to drive acceptance...through cost savings ... that is a long hard slog ..
Ann: Medgate extends European ResAppDx trial, page-40
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)